A two-drug regimen of Regeneron’s fianlimab and Libtayo didn’t significantly outperform Keytruda in a late-stage study, a ...
After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – and saving patients' lives.
A drug widely used to treat asthma and allergies may also help fight aggressive cancers, reports a new Northwestern Medicine ...
Sabari, MD, discusses exploring combination approaches as the next research step with zongertinib in patients with HER2 ...
A team led by Spaniard David Lagares is searching for a treatment for pulmonary fibrosis and other ailments associated with ...
Discover how subcutaneous melanoma immunotherapy replaces IV infusions, cutting clinic time while delivering the same proven ...
A drug widely used to treat asthma and allergies may also help fight aggressive cancers, reports a new Northwestern Medicine ...
Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy ...
Ultimately, Dr. Minn notes, success in immuno-oncology will be measured in multiple ways: Scientifically, by the depth of ...
Lilit Karapetyan, MD, MS, discusses the importance of considering TIL therapy for melanoma in advance and not as a last ...
From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results